Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center,Double-Blind,Randomized,Controlled Clinical Trial of Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3

NCT00565396 is registered in ClinicalTrials.gov with Shanghai Municipal Health Bureau as lead sponsor.

NCT NCT00565396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00565396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center,Double-Blind,Randomized,Controlled Clinical Trial of Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3
Lead sponsor
Shanghai Municipal Health Bureau
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2004
Completion date
July 31, 2008
Enrollment
400 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

angiotensin ii type 1 receptor blockers, angiotensin-converting enzyme inhibitors, chronic kidney insufficiency, proteinuria